Avril Biopharma can design and manufacture bespoke, gene-based synthetic biology products.  Our business model is focused on simplifying manufacturing for next-generation medical and veterinary products.  We are developing technologies and partnerships to make complex, custom-made, biological

This invention pertains to a method for chemically synthesising novel classes of silver complexes that target specific forms of cancer with demonstrable anticancer activity in cell culture (in vitro). Most noteworthy is thus far, these complexes have better preliminary results than standard...

Treating relatively fine bone fractures is challenging, as mechanisms to promote and correct bone growth used in large fractures are not suitable. Wits researchers have developed an injectable compound which is liquid at room temperature and becomes solid at body temperature that meets this need. It...

Wits researchers have developed a compound for the treatment of age-related diseases, such as cancer and cellular ageing. The compound occurs naturally in the body, and reduces the effects of telomerase activity in cells in a manner that prevents ageing of the cells. The compound, a protein fragment...

Surfactants are amphipathic molecules with both hydrophilic and hydrophobic moieties that partition preferentially at the interface between fluid phases such as oil/water or air/water interfaces. Such characteristics confer excellent detergency, emulsifying, foaming, and dispersing traits, which...

The Innovation and Health Summit provides the platform for experts, specialists, researchers, investors, developers and innovators related to obesity, heart disease, diabetes and related innovation and technology provides a great opportunity to cross-reference and share solutions with a broad...

Event start date
Event end date

The invention relates to a process for producing protein microparticles in dilute organic acid solutions and without the presence of an alcohol such as ethanol. The microparticles are formed by dissolving a cereal prolamin protein in a concentrated organic acid solution with agitation and then...

South African Nuclear Energy Corporation (NECSA) and its subsidiary NTP Radioisotopes are developing prostate specific membrane antigen (PSMA-11) kits for Ga-68 radiolabelling for the PET based diagnosis of prostate cancer.   The kits will be based on a 1-vial concept instead of the conventional 3...